Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Martek Pursues Cheaper DHA Cost Structure To Give Ingredient Wider Appeal

Sep 29 2003

• By The Tan Sheet

Related Content

Nestle Restages Good Start Brand, Adds ARA, DHA-Enriched Formula

Sep 29 2003

Martek Production Capacity Expected To Reach $200 Mil.-$250 Mil. in 2004

Jun 09 2003

Additional Topics

OTC Drugs Consumer

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window